220001-93-4Relevant articles and documents
CGRP ANTAGONIST COMPOUNDS
-
Page/Page column 59; 60, (2020/12/30)
The disclosures herein relate to novel compounds of Formula (1): and salts thereof, wherein A1, A2, Q, X, R1, R2 and R3 are defined herein, and their use in treating, preventing, ameliorating, control
6-pyrrolidin-2-ylpyrindine derivatives, their preparation and application in therapy
-
, (2008/06/13)
Compound corresponding to the general formula (I) in which R1 represents a hydrogen atom, a (C1-C4)alkyl group or a phenyl(C1-C4)alkyl group, R2 represents a hydrogen atom or a (C1-C4) alkyl group, and R3, R4 and R5 each represent a hydrogen or halogen atom or a trifluoromethyl, cyano, hydroxyl, (C1-C6)alkyl or (C1-C6) alkoxy group.